According to documents submitted to the SEC, biotechnology company Avai Bio Inc and Ainnova Tech have agreed, as of May 7, 2026, to jointly terminate their previously established joint venture and related licensing agreements.

老虎证券2026/05/08 20:35

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Bertelsmann plans merger of Brazil’s Afya and YDUQS to expand education business

Bitget•2026/09/24 05:02

Sivers Semiconductors names Marc Pegulu head of Wireless unit

Bitget•2026/09/24 05:01

Swiss Franc strengthens ahead of SNB policy decision

FXStreet•2026/09/24 04:57

US Treasury sell-off triggers massive waves in global bond markets! Global average yields approach the 4% threshold, Japan's 10-year hits a 30-year high

On Thursday, the global government bond sell-off intensified, pushing the average yield close to 4%, a level not seen since 2007.

智通财经•2026/09/24 04:06